To obtain a clinically applicable siRNA (small interference RNA) targeting an AR (androgen receptor) gene.
The double-stranded siRNA is a double-stranded siRNA that targets an AR gene and is a double-stranded siRNA of 21 bases comprising 19 base pairs and 2 base 3' terminal overhangs or a double-stranded siRNA of blunt end comprising 27 base pairs in which the sequence of the 19 base pairs is a specific sequence and the sequence of the 27 base pairs is a specific sequence. Mediating an AR gene-specific RNAi while avoiding an off-target effect and interferon response, the double-stranded siRNA is clinically applicable and is useful in the field of a therapy and a pharmaceutical composition using an AR as a target molecule, for example, in the field of a therapy and a pharmaceutical composition related to a cancer therapy including prostatic cancer.
COPYRIGHT: (C)2007,JPO&INPIT
Hiroyuki Hamakawa
JP2005529153A | ||||
JP2005061717A1 | ||||
JP2006006262A |
WO2005074995A1 | ||||
WO2004045543A1 |
BENYI LI, Annual Report for the Project W81XWH-04-1-0214, University of Kansas Medical School, 2005年2月
Cancer Cell Int., 2005年, 第5巻, 8
Virology, 2005年, 第336巻, 51-59ページ
Database DDBJ/EMBL/GenBank[online], Accession No.NM_000044,
Cancer Res., 2004年, 第64巻, 3365-3370ページ
N Engl J Med., 1995年, 第332巻, 1393-1398ページ